Albendazole Drug Index

albendazole Following 4 weeks of treatment with albendazole , 12 patients' plasma concentrations of albendazole sulfoxide were approximately 20%

Ivermectin–albendazole showed a good safety profile, with mostly mild and transient adverse events More moderate and severe adverse events were albendazole Albendazole is a benzimidazole carbamate with anthelmintic effects against tissue parasites It is thought to exhibit its anthelmintic effect by inhibiting